
Built on Calanus Oil and ORIVO-verified fish oil, the concept targets brands seeking faster, differentiated omega-3 product development.
FMC inherits an established omega-3 fish oils business.
By acquiring EPAX, FMC inherits the Norwegian company’s fish oil production facilities in Alesund, Norway and Seal Sands, UK. As part of the financial agreement, EPAX will continue to supply highly concentrated fish oils to its former owner, Trygg Pharma Group AS.
